Apr 24 |
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
|
Apr 9 |
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
|
Apr 4 |
bioAffinity Technologies files to sell 1.63M shares for holders
|
Apr 1 |
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 8 |
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
|
Mar 8 |
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
|
Mar 6 |
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
|
Mar 6 |
BioAffinity Technologies to raise $2.5M from stock offering and private placement
|
Mar 6 |
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
|
Mar 5 |
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
|